Status: Recruiting
Nasopharyngeal Carriage of S. Pneumoniae
This nasopharyngeal (NP) carriage surveillance study was requested by the European Agency for the Evaluation of Medicinal Products as a post-licensing commitment to determine whether the use of the pneumococcal conjugate vaccines (PCVs) including 7 then 13 valents (introduced in 2001 and 2010, respectively) caused a shift in the distribution of Streptococcus pneumoniae serotypes in children with acute otitis media and modified the resistance of this bacterial species to antibiotics.
Participants needed: 25,760
Trial details
Age: 6-15Biological sex: AllType: InterventionalSponsor: Association Clinique Thérapeutique Infantile du val de MarneUpdated: Mar 19, 2026Locations: 1
Eligibility criteria
both sexes [+5]
severe underlying disease, [+2]